神经节丛消融对胸腔镜房颤消融术后早期复发的影响:AFACT研究事后分析
基于随机对照AFACT研究的事后分析纳入235例晚期房颤行胸腔镜消融患者,比较附加神经节丛(GP)消融与不消融。GP消融未降低早期复发率(36例 vs 35例,p=0.730),但首次复发时间更晚(24天 vs 14天,p=0.046)。GP消融组早期复发与晚期复发相关,提示自主神经触发与既有基质共同作用,但属探索性假设。
要点
- 附加GP消融未减少胸腔镜房颤消融术后早期复发率。
- GP消融组首次早期复发时间晚于非GP组(24天 vs 14天)。
- GP消融组早期复发与晚期复发相关,非GP组无此关联。
核心结论
- 附加GP消融与首次早期复发时间推迟相关,但未降低总体早期复发率。
- GP消融组中早期复发与晚期复发相关,提示早期复发可能反映短暂自主神经触发与既有基质的共同作用。
研究设计与样本
- 基于随机AFACT研究的事后分析,比较晚期房颤行单纯胸腔镜消融联合或不联合GP消融的患者。
- 共纳入235例患者,早期复发定义为术后90天内房颤或房性心动过速复发,采用Cox模型评估时间依赖性效应。
主要发现
- 早期复发中45例(63%)发生在术后30天内。
- GP消融组首次复发晚于非GP组(24 [14–34]天 vs 14 [11–24]天,p=0.046)。
- GP消融组中致心律失常基质标志(年龄、左房容积指数、糖尿病、CHA2DS2-VASc评分、持续性房颤)与早期复发相关。
- GP消融组早期复发与晚期复发相关,非GP组无此关联。
关键数值与推荐
- 早期复发定义:术后90天内房颤或房性心动过速复发。
- GP消融组首次复发中位时间24天(IQR 14–34),非GP组14天(IQR 11–24),p=0.046。
- 早期复发率GP组36例 vs 非GP组35例,p=0.730。
临床怎么用
- 附加GP消融不应以降低早期复发率为目的,但可预期首次复发时间推迟。
- GP消融组早期复发者需警惕后续晚期复发,加强随访。
- 早期复发评估应结合患者基质特征(年龄、左房容积指数、糖尿病、CHA2DS2-VASc评分、持续性房颤)。
局限性
- 为事后探索性分析,机制结论仍属假设生成。
- 早期复发与晚期复发的关联分析未在非GP组中观察到,需进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Adjunctive ganglionated plexus (GP) ablation did not reduce early AF recurrence after thoracoscopic AF ablation but was associated with a later first recurrence. In the GP-ablation group, early recurrence was associated with late recurrence; this exploratory finding is compatible with, but does not establish, a greater contribution of pre-existing substrate. ABSTRACT Background Early recurrences of atrial fibrillation (AF) after ablation are often considered transient. However, they may be caused by a combination of temporary and permanent proarrhythmogenic factors. Objective We evaluated whether adjunctive GP ablation was associated with the timing and clinical implications of early AF recurrence, and explored the hypothesis that autonomic mechanisms contribute to early recurrence. Methods Using data from the randomized AFACT study, we compared patients with advanced AF who underwent stand-alone thoracoscopic ablation with or without GP ablation. Early recurrence was defined as AF or atrial tachycardia recurrence within 90 days postoperative. Cox models were used to assess time-dependent effects and identify clinical predictors. Results A total of 235 patients were included in the current analysis. Seventy-one patients had early recurrence: 36 in the GP ablation group and 35 in the non-GP ablation group (p = 0.730). Of these, 45 (63%) occurred within the first 30 days. Patients in the GP ablation group had their first recurrence later than those in the non-GP group (24 [14–34] vs. 14 [11–24] days, p = 0.046). In the GP ablation group, markers of arrhythmogenic substrate (i.e., age, left atrial volume index, diabetes, CHA2DS2-VASc score, and persistent AF) were associated with early recurrence. Additionally, early recurrence was associated with late recurrence in the GP ablation group, but not in the non-GP ablation group. Conclusion Adjunctive GP ablation was associated with later onset of first early recurrence, while the overall early recurrence rate was not reduced. In the GP ablation group, early recurrence was associated with subsequent late recurrence. These exploratory findings are compatible with a model in which early recurrence reflects both transient autonomic triggers and pre-existing substrate, but this mechanism remains hypothesis-generating. Clinical Trial Registration: ClinicalTrials.gov Identifier: NCT01091389.
引用
- Journal of Cardiovascular Electrophysiology:Impact of Ganglionated Plexus Ablation on Early Recurrence After Thoracoscopic Atrial Fibrillation Ablation: A Post Hoc Analysis of the AFACT Study
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。